Display options
Share it on

Balkan J Med Genet. 2012 Dec;15(2):55-60. doi: 10.2478/bjmg-2013-0007.

Human leukocyte antigen-b27 and disease susceptibility in vojvodina, serbia.

Balkan journal of medical genetics : BJMG

S Vojvodić, D Ademović-Sazdanić, Busarčević

Affiliations

  1. Department for Laboratory Testing, Tissue Typing Compartment, Institute for Blood Transfusion of Vojvodina, Novi Sad, Serbia.

PMID: 24052732 PMCID: PMC3776663 DOI: 10.2478/bjmg-2013-0007

Abstract

There are numerous studies showing the role of human leukocyte antigens (HLAs) related with susceptibility or resistance to certain diseases. The aim of this study was to determine the association of HLA-B27 with ankylosing spondylitis (AS), polyarthralgia, lumboishialgia, acute anterior uveitis (AAU), psoriatic arthritis (PA), synovitis coxae and rheumatoid arthritis (RA) in patients from Vojvodina, Serbia. An HLA I class typing was performed by the serological immunomagnetic two-color fluorescence method using peripheral blood T lymphocytes in 97 patients and 224 healthy controls from the population of Vojvodina, Serbia. We calculated HLA-B27 frequencies, relative risk (RR), ethiologic fraction (EF), e.g., population attributive risk, when RR was greater than 1, while, preventive fraction (PF) was calculated when RR was lower than 1. This study revealed the strongest association of AS with HLAB27 antigen: RR = 25.0, while the EF was greater than 0.15, respectively. The χ(2) test showed the significant difference (p <0.05) in HLA-B27 in patients with AS in comparison to controls (χ(2) = 52.5). It was concluded that there is a positive association of HLA-B27 with AS and that HLA-B27 can serve as a marker for predisposition to diseases.

Keywords: Ankylosing spondylitis (AS); Cytotoxic T cells (CTL); Heavy chain (HC); Human leukocyte antigen(s) (HLAs); Major histocompatibility complex (MCH); Relative risk (RR); Spondyarthropathies (SpA); T cell receptors (TCR)

References

  1. Prion. 2009 Jan-Mar;3(1):15-26 - PubMed
  2. Arthritis Res Ther. 2009;11(1):214 - PubMed
  3. Clin Microbiol Rev. 2004 Apr;17(2):348-69 - PubMed
  4. Tissue Antigens. 1981 Nov;18(5):356-63 - PubMed
  5. Eye (Lond). 2007 Jan;21(1):33-9 - PubMed
  6. Tissue Antigens. 1986 Nov;28(5):301-12 - PubMed
  7. Iran J Immunol. 2011 Jun;8(2):85-9 - PubMed
  8. Immunogenetics. 1999 Nov;50(3-4):220-7 - PubMed
  9. Rheumatology (Oxford). 2002 Aug;41(8):857-68 - PubMed
  10. J Biol Chem. 2002 Dec 6;277(49):47844-53 - PubMed
  11. Tissue Antigens. 1982 Apr;19(4):259-68 - PubMed
  12. Rheum Dis Clin North Am. 2009 Feb;35(1):21-44 - PubMed
  13. Curr Opin Rheumatol. 2005 Jul;17(4):400-5 - PubMed
  14. Rheumatology (Oxford). 2002 Dec;41(12):1375-9 - PubMed
  15. J R Soc Med. 2004 Jan;97(1):10-4 - PubMed
  16. Int J Immunogenet. 2010 Dec;37(6):513-6 - PubMed
  17. Genet Mol Res. 2011 Dec 02;10(4):3987-91 - PubMed
  18. Arthritis Res. 2002;4 Suppl 3:S153-8 - PubMed
  19. Transplant Proc. 1987 Feb;19(1 Pt 1):655-7 - PubMed
  20. Immunol Rev. 1983;70:193-218 - PubMed
  21. Surv Ophthalmol. 2005 Jul-Aug;50(4):364-88 - PubMed
  22. Int J Immunogenet. 2018 Feb;45(1):35-39 - PubMed

Publication Types